The credible Prostate Cancer Diagnostics Market report has been produced with the systematic gathering and analysis of information about individuals or organisations conducted through social and opinion research. With the studies, insights and analysis mentioned in the report, get comprehensible ideas about the market place and take business decisions quickly and easily. This worldwide advertising report comprises of all the organization profiles of the key players and brands. Market definition covered in Prostate Cancer Diagnostics business report studies the market drivers and market restraints with which businesses can get idea of whether to increase or decrease the production of a particular product.
Prostate cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 20.1% in the forecast period of 2021 to 2028 and is expected to reach USD 8,255.27 million by 2028 from USD 3,109.98 million in 2020. Increasing focus on the disease burden and increasing awareness regarding the disease are the major drivers which are propelling the market in the forecast period.
Download Sample PDF of Prostate Cancer Diagnostics Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-prostate-cancer-diagnostics-market
Prostate cancer diagnostics play an important role in the early detection and efficient management of the disease. It includes usage of instruments, reagents & consumables and accessories. The PSA testing is the most common preliminary diagnosis of prostate cancer which may or may not require confirmatory tests for detection of the cancer.
Global Prostate Cancer Diagnostics Market Scope and Market Size
Prostate cancer diagnostics market is categorized into eight notable segments which are based on the product type, diagnostics type, age group, type, stage, sample type, end users and distribution channel.
· On the basis of product type, the prostate cancer diagnostics market is segmented into instruments, reagents & consumables and accessories. In 2021, reagents & consumables segment is dominating in the prostate cancer diagnostics market as PSA is the primary test recommended for preliminary testing. PSA measures protein made by cells in prostate gland, high levels of PSA in blood may be an indicator of prostate cancer with availability of PSA screening and ease of transportation and storage of samples.
· On the basis of diagnostics type, the prostate cancer diagnostics market is segmented into preliminary screening tests and confirmatory tests. In 2020, preliminary screening tests segment is dominating in the prostate cancer diagnostics market as the number of preliminary tests surpass the number of confirmatory tests by significant percentage.
· On the basis of age group, the prostate cancer diagnostics market is segmented into adult, pediatric and geriatrics. In 2021, geriatrics segment is dominating in the prostate cancer diagnostics market as around 60% of cases are diagnosed in men over 65 year of age. The average age of prostate cancer diagnostics is 66 years. The disease rarely occurs in those younger than 40. The number of new cases diagnosed in black men is 60% higher than to the number of new cases diagnosed in white men.
· On the basis of type, the prostate cancer diagnostics market is segmented into prostatic adenocarcinoma, small cell carcinoma and others. In 2020, prostatic adenocarcinoma segment dominates the prostate cancer diagnostics market because more than 95 percent of prostate cancers are adenocarcinomas which develop in the gland cells and line of the prostate gland. Nearly, all the men with prostate cancer have this type. It is the second leading cause of cancer-related death in men. Once the cancer reaches a certain stage, then the abnormal cells spread to other parts of the body, hence causing metastasis which leads to dominating the segment of the market.
· On the basis of stage, the prostate cancer diagnostics market is segmented into localized prostate cancer, recurrent/advanced prostate cancer and castration-resistant prostate cancer (metastatic and non-metastatic). In 2021, localized prostate cancer segment dominates the prostate cancer diagnostics market as approximately 80 percent to 85 percent of all prostate cancers are detected in the local or regional stages which represent stages I, II and III. Most of the men diagnosed and treated at the local or regional stages will be disease-free after five years. This type of cancer does not spread in any of the nearby tissues or to distant parts of the body. The stages present in localized prostate cancer are stage 1 and 2. The growth of tumor in low-risk localized prostate cancer is slow.
· On the basis of sample type, the prostate cancer diagnostics market is segmented into blood, tissue, urine and others. In 2021, blood segment is dominating the prostate cancer diagnostics market as blood is the primary sample for the most common preliminary test that is PSA test and due to easy availability of blood, less complex procedure of blood sample collection doesn’t take much time which is expected to dominate the prostate cancer diagnostics market.
· On the basis of end user, the prostate cancer diagnostics market is segmented into independent diagnostic laboratories, hospitals, cancer research institutes, clinics, ambulatory surgical centers and others. In 2021, Independent diagnostic laboratories segment is dominating the prostate cancer diagnostics market as this segment is specialized in conducting various prostate cancer diagnostics. Moreover, independent diagnostic laboratories enable the facilitation of robust, on-time, cost-effective and high quality diagnostic care and services in safe healthcare environment and are convenient for consulting physician/healthcare institution to outsource bulk diagnostics tests to independent diagnostic laboratories for better customer services.
· On the basis of distribution type, the prostate cancer diagnostics market is segmented into direct tender and retail sales. In 2021, direct tender segment dominates the prostate cancer diagnostics market as they are the primary source of procurement of reagents, consumables, devices and accessories by healthcare organizations and diagnostic labs. With the increasing cost of healthcare, healthcare service providers are focusing on better services for customers along with reducing the overall cost. The procurement of products through direct tender is highly cost effective for healthcare providers.
Browse a Detailed Summary of the Prostate Cancer Diagnostics Market Research Report @ https://www.databridgemarketresearch.com/reports/global-prostate-cancer-diagnostics-market
Some Of The Important Questions Covered In This Study Are As Follows:
· What Are The Prominent Growth Factors That Will Harness Growth For The Prostate Cancer Diagnostics Market During The Forecast Period?
· Which End-Use Industry Will Garner Considerable Growth for the Prostate Cancer Diagnostics Market?
· Which Region Will Emerge As A Champion Growth-Contributor During The Assessment Period?
· What Are the Obstacles Surrounding the Market?
· Study the growth outlook of the global Prostate Cancer Diagnostics Market scenario, including production, consumption, history and forecast.
· Learn consumption pattern and impact of each end use on the Prostate Cancer Diagnostics Market growth.
· Investigate the recent R&D projects performed by each Prostate Cancer Diagnostics Market player
Browse More Reports
https://www.databridgemarketresearch.com/reports/europe-prostate-cancer-diagnostics-market
https://www.databridgemarketresearch.com/reports/asia-pacific-prostate-cancer-diagnostics-market
https://www.databridgemarketresearch.com/reports/north-america-prostate-cancer-diagnostics-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian